by The DNA Synthesizer Market is estimated to be valued at US$ 4.30 Bn or billions in 2023 and is expected to exhibit a CAGR of 20% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
DNA synthesizers are equipment used for the artificial synthesis of genetic material, DNA, which involves linking individual nucleotides into long oligonucleotide strands. They are used across various end-use industries including biotechnology and pharmaceutical companies, academic institutes and clinical research labs for functional genomics, molecular diagnostics and DNA sequencing applications. Advancements in DNA synthesis technology has enabled rapid, large-scale and cost-effective DNA production which has tremendously boosted biomedical research activities in recent years.
Market Dynamics:
The growing demand for custom synthesized DNA from biotech and pharmaceutical companies for gene sequencing, molecular diagnostics and biomedical research is a key factor driving the growth of DNA synthesizer market. Secondly, continuous technological advancements in DNA synthesis methods along with reduction in DNA synthesis costs have made DNA readily accessible, further fueling the market growth. Initiatives by government and private organizations to map genomes and sequence DNA have also propelled the demand for DNA synthesizers. Additionally, increasing complex molecular biology research activities for conditions like cancer and neurodegenerative diseases have augmented the usage rates of DNA synthesizers across leading academic institutions during the forecast period.
Segment Analysis
The global DNA Synthesizer market can be segmented by product type into Oligonucleotide synthesizer and gene synthesizer. The oligonucleotide synthesizer segment currently dominates the market due to the wide use of oligonucleotides in various downstream applications like DNA cloning and sequencing. These synthesizers are used to synthesize short oligonucleotides ranging from 10 to 200 nucleotides that are used as primers, probes and for site-directed mutagenesis.
PEST Analysis
Political: Stable political landscapes and supportive government policies in many countries promoting life science research and development are positively impacting the DNA Synthesizer market.
Economic: Rising investments in biotechnology and pharmaceutical industries along with increasing global healthcare expenditure are fueling market growth.
Social: Growing awareness about customized medicine, genetic testing and biotechnology is creating demand for DNA synthesizers.
Technological: Advancements in solid-phase oligonucleotide synthesis technologies and automation offering high-throughput oligo synthesis are augmenting the market expansion.
Key Takeaways
The global DNA Synthesizer Market Growth is expected to witness high growth, exhibiting a CAGR of 20% over the forecast period, due to increasing investments in biotechnology and life science research. The market size for 2023 is estimated at US$ 4.30 Bn.
Regionally, North America is projected to dominate the global market during the analysis period. This is attributed to strong research infrastructure, rising prevalence of chronic diseases and growing focus on precision medicine and genomic research in the region. Asia Pacific is expected to exhibit the fastest growth rate owing to growing R&D spending, rising affordability and improving healthcare scenario.
Key players operating in the DNA Synthesizer market are Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, Expedeon AG, New England Biolabs, Nippon Genetics, and LGC Biosearch Technologies. The market is highly consolidated with top players accounting for over 70% share. Agilent Technologies, Thermo Fisher Scientific and Merck KGaA control a major portion of the global DNA synthesizer industry.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
